Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Biogen Idec (NQ: BIIB)
312.58 USD  -2.23 (-0.71%)
Official Closing Price  /  Updated: 8:10 PM EDT, Sep 23, 2016  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 881,641
Open 312.58
Bid (Size) 312.58 (1500)
Ask (Size) 312.62 (100)
Prev. Close 314.81
Today's Range 312.11 - 317.32
52wk Range 223.02 - 333.65
Shares Outstanding 219,120,762
Dividend Yield N/A
Performance
YTD
+6.10%
+6.10%
1 Month
+1.87%
+1.87%
3 Month
+39.17%
+39.17%
6 Month
+24.16%
+24.16%
1 Year
+9.76%
+9.76%
Top News
More News
Stocks Higher Ahead Of Fed; Surging Biotechs Give Nasdaq A Boost
Stocks remained modestly higher Tuesday heading into the last hour of trade. Biotechs muscled higher, but homebuilders slumped on weak housing data. Read More
category Stock Market Today
from Investor's Business Daily
Stocks Hold Modest Gains Near Midday; Biotechs Strong Again
Major averages maintained marginal gains near the noon hour Tuesday as the two-day Fed meeting got underway. Read More
category Stock Market Today
from Investor's Business Daily
More News
Read More
Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
category Allergan , Liver Diseases , Analyst Color , and 15 more.
from Benzinga
New Data Presented at ECTRIMS Reinforce Efficacy of ZINBRYTA™ (Daclizumab) and Support Long-Term Safety Profile
from Business Wire News Releases
Biogen to Report Third Quarter 2016 Financial Results on October 26, 2016
from Business Wire News Releases
New Data Affirm Strong Efficacy and Well-Characterized Safety Profile of TECFIDERA® in Both Clinical Studies and Real-World Setting
from Business Wire News Releases
Biogen Idec Has Returned 23.9% Since SmarTrend Recommendation (BIIB)
from Comtex SmarTrend® News Briefs
Notable Thursday Option Activity: ORCL, NRG, BIIB
category Dividends
from Dividend Channel
Notable Thursday Option Activity: ORCL, NRG, BIIB
category Stocks
from Market News Video
3 Ways Ionis Pharmaceuticals, Inc. Is Beating the Competition
category ARWR , BIIB , IONS , and 1 more.
from Motley Fool
Could This Alzheimer’s Disease Drug Really Be Worth $20 Billion?
category BIIB , LLY
from Motley Fool
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here